Margin status impact on recurrence of phyllodes tumors in high-risk groups: a retrospective observational study

被引:1
|
作者
Ranjbar, Aliyeh [1 ]
Zangouri, Vahid [1 ,2 ]
Shokripour, Mansoureh [3 ]
机构
[1] Shiraz Univ Med Sci, Breast Dis Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Gen Surg Dept, Surg Oncol Div, Shiraz, Iran
[3] Shiraz Univ Med Sci, Med Sch, Dept Pathol, Shiraz, Iran
关键词
Phyllodes tumour; Local recurrence; Surgical margins; Risk factor; LOCAL RECURRENCE; BREAST; FEATURES; BENIGN; MANAGEMENT; EXCISION;
D O I
10.1186/s12885-023-11805-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Phyllodes tumor (PT) is an fibroepithelial tumor with potential for local recurrence. The optimal margin for surgical resection of PT is still debated, particularly in cases of positive margins. This study aimed to identify the risk factors for phyllodes tumor recurrence and the effect of a free margin on tumor recurrence by considering these risk factors.Materials and methods This is a retrospective observational study of patients diagnosed with PT who had undergone surgical management. The data were collected from medical records from 2001 to 2020 in the breast clinic of Shahid Motahhari Clinic of Shiraz. Patients were followed up for at least 3 years after the operation to be checked for local recurrence or distant metastasis at regular intervals.Results This retrospective study included 319 patients with PT who underwent surgical management. Of these patients, 83.9% (n = 267), 7.6% (n = 24), and 8.5% (n = 27) were classified as benign, borderline, and malignant, respectively. 8.8% of all patients and 7.6% of non-malignant cases experienced local recurrence, and risk factors for recurrence included oral contraceptive use, smoking, size > 4 cm, stromal overgrowth, and stromal cell atypia. A negative surgical margin decreased the prevalence of recurrence in tumors > 4 cm and with stromal overgrowth significantly.Conclusion The study found that a negative margin in all patients did not reduce the recurrence rate in benign and borderline phyllodes tumors, suggesting close follow up as a reasonable alternative. However, a negative margin may be effective in reducing recurrence in certain high-risk groups.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Evaluation of predictor risk factors and calculation of a margin index for ipsilateral invasive recurrence following treatment of DCIS: A 15-year observational study
    Brooks, Marion
    Classe, Jean-Marc
    Wernert, Romuald
    Raro, Pedro
    Paillocher, Nicolas
    Campion, Loic
    Descamps, Philippe
    Oger, Anne Sophie
    BREAST JOURNAL, 2020, 26 (05) : 1067 - 1068
  • [22] High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant Treatment
    Trosman, Samuel J.
    Zhu, Angela
    Nicolli, Elizabeth A.
    Leibowitz, Jason M.
    Sargi, Zoukaa B.
    LARYNGOSCOPE, 2021, 131 (01) : E136 - E143
  • [23] Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study
    Neron, Mathias
    Sajous, Christophe
    Thezenas, Simon
    Piperno-Neumann, Sophie
    Reyal, Fabien
    Lae, Marick
    Chakiba, Camille
    Penel, Nicolas
    Ryckewaert, Thomas
    Honore, Charles
    Bertucci, Francois
    Monneur, Audrey
    Salas, Sebastien
    Duffaud, Florence
    Saada-Bouzid, Esma
    Isambert, Nicolas
    Brahmi, Mehdi
    Ray-Coquard, Isabelle
    Blay, Jean-Yves
    Firmin, Nelly
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1693 - 1699
  • [24] Novel Insights for Patients with Multiple Basal Cell Carcinomas and Tumors at High-Risk for Recurrence: Risk Factors, Clinical Morphology, and Dermatoscopy
    Sgouros, Dimitrios
    Rigopoulos, Dimitrios
    Panayiotides, Ioannis
    Apalla, Zoe
    Arvanitis, Dimitrios K.
    Theofili, Melpomeni
    Theotokoglou, Sofia
    Syrmali, Anna
    Theodoropoulos, Konstantinos
    Pappa, Georgia
    Damaskou, Vasileia
    Stratigos, Alexander
    Katoulis, Alexander
    CANCERS, 2021, 13 (13)
  • [25] Effect of radiation therapy on patients with stage T3 or T4 malignant phyllodes tumors: a retrospective observational study based on SEER
    Zhang, Gongyin
    Yang, Ping
    Zeng, Jinsheng
    Wei, Changlong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (01)
  • [26] Excision Margin and Survival in Patients with High-Risk, Primary Cutaneous Melanoma: A Retrospective Study Based on Surveillance Epidemiology and End Result (SEER) Database
    Xu, Meng-Nan
    Rao, Qiu
    DERMATOLOGY, 2022, 238 (03) : 534 - 541
  • [27] Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention An Observational Registry Study
    Iversen, Allan Z.
    Galatius, Soeren
    Pedersen, Sune
    Madsen, Jan K.
    Jensen, Jan S.
    DRUGS & AGING, 2011, 28 (05) : 369 - 378
  • [28] Screening for depression in high-risk groups: prospective cohort study in general practice
    Baas, Kim D.
    Wittkampf, Karin A.
    van Weert, Henk C.
    Lucassen, Peter
    Huyser, Jochanan
    van den Hoogen, Henk
    van de Lisdonk, Eloy
    Bindels, Patrick E.
    Bockting, Claudi L.
    Ruhe, Henricus G.
    Schene, Aart H.
    BRITISH JOURNAL OF PSYCHIATRY, 2009, 194 (05) : 399 - 403
  • [29] Clinical outcomes of endoscopic resection for the treatment of intermediate- or high-risk gastric small gastrointestinal stromal tumors: a multicenter retrospective study
    Xu, Enpan
    Shi, Qiang
    Qi, Zhipeng
    Li, Bing
    Sun, Huihui
    Ren, Zhong
    Cai, Shilun
    He, Dongli
    Lv, Zhengtao
    Chen, Zhanghan
    Zhong, Liang
    Xu, Leiming
    Li, Xiaobo
    Xu, Shuchang
    Zhou, Pinghong
    Zhong, Yunshi
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024, 38 (06): : 3353 - 3360
  • [30] Development and external validation of a nomogram for individualized adjuvant imatinib duration for high-risk gastrointestinal stromal tumors: A multicenter retrospective cohort study
    Liu, Ruolin
    Wu, Yingxin
    Gong, Jin
    Zhao, Rui
    Li, Li
    Wan, Qianyi
    Lian, Nan
    Shen, Xiaoding
    Xia, Lin
    Shen, Yuhou
    Xiao, Haitao
    Wu, Xiaoting
    Chen, Yi
    Cen, Ying
    Xu, Xuewen
    CANCER MEDICINE, 2022, 11 (16): : 3093 - 3105